UCSF

Tagged: Oligonucleotides

Gartner named one of Popular Science’s “Brilliant 10” of 2015

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is...

Thomas James, PhD

Professor

I retired from full-time service at UCSF at the end of June, 2012. However, I went on Recall status a month later to do research, which diminishes each year. I needed to finish some projects that were still funded via grants during the initial year and continue with another funded project...

Zev Gartner, PhD

Professor

My laboratory is working to understand how cells assemble into multicellular tissues, how the structure of tissues controls the behavior of individual cells, and how changes to tissue structure drive the progression of diseases like cancer. Toward these goals, we build, perturb, and model human...